Sino Biological Launches Innovative XPressMAX™ for Rapid Protein Synthesis in Antibody Drug Discovery
Sino Biological, Inc., a leading name in recombinant technology, has recently unveiled its groundbreaking XPressMAX™ Cell-Free Protein Synthesis Kit. Designed to optimize high-throughput antibody drug discovery via AI-driven screening, this cutting-edge solution promises to revolutionize the research landscape.
The XPressMAX™ Cell-Free Protein Synthesis Kit (Catalog No. CFKIT02) harnesses advanced cell-free synthesis technologies to deliver a rapid and efficient in vitro production of target proteins and antibodies. This innovative kit directly addresses the limitations often encountered with traditional cell-based expression systems, allowing researchers to streamline the identification and refinement processes for antibody candidates.
Leveraging a fully supplemented E. coli lysate, the XPressMAX™ enables direct protein synthesis from plasmid or PCR templates. It specifically caters to the nuanced needs of antibody drug development, facilitating swift expression and validation of various protein formats including VHH, scFv, Fab, and mini-proteins. Sino Biological's achievement with this kit is nothing short of remarkable—it establishes a cell-free high-throughput platform capable of validating over 2,000 scFv/VHH molecules in just three to four weeks, keeping pace with the rapid iterations demanded by AI technologies.
Dr. Rob Burgess, Chief Business Officer of Sino Biological US, Inc., emphasizes that, "Our XPressMAX™ is a significant advancement in research tools and reagents for next-generation therapeutic discovery. By coupling rapid, reliable protein expression with intelligent screening, we assist our partners in expediting their antibody discovery timelines without compromising quality."
Dr. Jie Zhang, CEO of Sino Biological, adds, "AI is revolutionizing antibody screening demands, requiring expression systems capable of keeping up with its speed and throughput. The XPressMAX™ allows for rapid and successful expression of complex proteins in a mere three hours."
Researchers can visit www.sinobiological.com to learn more about the XPressMAX™ Cell-Free Protein Synthesis Kit, or they can request a free sample through the company's website.
Sino Biological is a global supplier of reagents and a contract research organization (CRO) specializing in the production of recombinant proteins and antibody development. With its bioprocessing center located in Houston, USA, and SignalChem Biotech in Canada (a part of Sino Biological), the company offers tailored solutions to meet various research needs worldwide. Serving researchers in over 90 countries, Sino Biological maintains a stringent quality management system across all its products, ensuring excellence and reliability in their offerings. Their commitment to advancing scientific research continues to drive their innovative solutions in the field.
A Revolutionary Approach to Protein Synthesis
The XPressMAX™ Cell-Free Protein Synthesis Kit (Catalog No. CFKIT02) harnesses advanced cell-free synthesis technologies to deliver a rapid and efficient in vitro production of target proteins and antibodies. This innovative kit directly addresses the limitations often encountered with traditional cell-based expression systems, allowing researchers to streamline the identification and refinement processes for antibody candidates.
Leveraging a fully supplemented E. coli lysate, the XPressMAX™ enables direct protein synthesis from plasmid or PCR templates. It specifically caters to the nuanced needs of antibody drug development, facilitating swift expression and validation of various protein formats including VHH, scFv, Fab, and mini-proteins. Sino Biological's achievement with this kit is nothing short of remarkable—it establishes a cell-free high-throughput platform capable of validating over 2,000 scFv/VHH molecules in just three to four weeks, keeping pace with the rapid iterations demanded by AI technologies.
Key Features of the XPressMAX™ Kit
- - Ultra-fast Synthesis: The entire synthesis process can be completed in as little as three hours.
- - High Success Rate: The kit boasts an impressive success rate of over 99%.
- - Support for Complex Disulfide Bonds: It ensures native folding and bioactivity without the need for additional boosters.
Dr. Rob Burgess, Chief Business Officer of Sino Biological US, Inc., emphasizes that, "Our XPressMAX™ is a significant advancement in research tools and reagents for next-generation therapeutic discovery. By coupling rapid, reliable protein expression with intelligent screening, we assist our partners in expediting their antibody discovery timelines without compromising quality."
Dr. Jie Zhang, CEO of Sino Biological, adds, "AI is revolutionizing antibody screening demands, requiring expression systems capable of keeping up with its speed and throughput. The XPressMAX™ allows for rapid and successful expression of complex proteins in a mere three hours."
Researchers can visit www.sinobiological.com to learn more about the XPressMAX™ Cell-Free Protein Synthesis Kit, or they can request a free sample through the company's website.
About Sino Biological
Sino Biological is a global supplier of reagents and a contract research organization (CRO) specializing in the production of recombinant proteins and antibody development. With its bioprocessing center located in Houston, USA, and SignalChem Biotech in Canada (a part of Sino Biological), the company offers tailored solutions to meet various research needs worldwide. Serving researchers in over 90 countries, Sino Biological maintains a stringent quality management system across all its products, ensuring excellence and reliability in their offerings. Their commitment to advancing scientific research continues to drive their innovative solutions in the field.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.